Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The company is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The firm is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.
최신 재무제표(Form-10K)에 따르면, Mushrooms Inc의 총 자산은 $0이며, 순손실입니다.
MSRM의 주요 재무 비율은 무엇인가요?
Mushrooms Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Mushrooms Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Mushrooms Inc 주요 수익원은 Mycelium for the Creation of Carbon Neutral Products이며, 최신 수익 발표에서 수익은 2,384입니다. 지역별로는 United States이 Mushrooms Inc의 주요 시장이며, 수익은 2,384입니다.